Walmart (WMT) possesses solid growth attributes, which could help it handily outperform the market.
The retail giant can continue to grow as it caters to consumers on tight budgets and makes a push into advertising, says a UBS analyst.
Walmart has shown resilience and growth in the face of challenges, with stock price outperforming market indices over the past three years. Q1 earnings showed strong performance, especially in international sales and e-commerce, setting high expectations for the upcoming Q2 report. Management's focus on supply chain innovation, omnichannel experience, and emerging segments like advertising and memberships will be key to Walmart's future growth and valuation.
Retail giant Walmart (NYSE: WMT ) was one of the best-performing stocks during the first half of the year. Year-to-date (YTD), WMT stock is up more than 32%, beating the S&P 500's 14% gain.
As Walmart and Amazon look to boost their margins through digital media sales, the two retail giants are sweetening the deal for potential advertisers.
Walmart's "Everyday Low Price" promise will be put to the test when it reports quarterly results, after rival Amazon.com's warning that customers had turned bargain hunters, pressuring the online shopping behemoth to forecast a weak current quarter.
Walmart (WMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Walmart (WMT) closed at $69.62 in the latest trading session, marking a -0.23% move from the prior day.
So far this year, the impossible has happened. The leader in e-commerce retail, which is supposed to have displaced the bricks-and-mortar part of the industry, isn't doing so, at least by stock market measures.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Walmart is expanding its “autoimmune-focused” specialty pharmacy business to more than 30 locations across nine states as retailers beef up the more lucrative aspects of the prescription drug business.